Hypertension Initiative Enrollment

WisPQC Hypertension Initiative Enrollment

Please complete this survey to enroll in the WisPQC Hypertension Initiative.

Name of site*
Address*
Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country
Name*
First Last
Title or position*
Email*

We will use this email address for communication related to the initiative. You will be able to add additional contacts below.
Do you want to add additional contacts?*
- Yes
- No
Additional contacts
You may enter names and email addresses for up to three additional contacts in the spaces below. If you would like to add others, please send an email to [email protected]
Name
First Last
Email
Do you wish to add another contact?
- Yes
- No
Name
First Last
Email
Do you wish to add another contact?
- Yes
- No
Name
First Last
Email
Measure Selection
Use this section to indicate interest in the measures.
Selection of measures is non-binding.
Measure 1: Maternal length of stay or documented outpatient follow-up*
- Yes
- No
- Unsure
Enrolled hospitals will increase the percent of maternity patients with gestational hypertension or preeclampsia of any severity*, regardless of timing of onset, who have given birth at equal to or over 20 weeks completed gestation with post-delivery length of stay (LOS) greater than or equal to 72 hours in the hospital or documented evidence of follow-up by 10% each month of the initiative.

*Includes eclampsia and HELLP syndrome.
Measure 1: Unsure
Please explain.
Measure 2: Consumer education*
- Yes
- No
- Unsure
Enrolled hospitals will increase the percent of postpartum maternity patients greater or equal to 20 weeks completed gestation receiving education on the signs and symptoms of postpartum preeclampsia prior to hospital discharge by 10% each month of the initiative.
Measure 2: Unsure
Please explain.
Measure 3: NICU admission*
- Yes
- No
- Unsure
Monitor percent of infants admitted to the NICU with maternal diagnosis of any type of hypertension or preeclampsia of any degree of severity* during pregnancy.

* Includes eclampsia and HELLP syndrome.
Measure 3: Unsure
Please explain.
Measure 4: Low-dose aspirin (81 mg daily) with risk factors for preeclampsia*
- Yes
- No
- Unsure
The percent of maternity patients of greater than or equal to 20 weeks completed gestation with chronic hypertension, history of preeclampsia, multifetal gestation, type 1 or 2 diabetes, renal disease, and/or autoimmune disease and took antiplatelet therapy (aspirin) during pregnancy will increase 10% each month of the initiative.
Measure 4: Unsure
Please explain.
Measure 5: Appropriate medical management in under 60 minutes*
- Yes
- No
- Unsure
The percent of maternity patients with new onset severe range hypertension (systolic BP ≥ 160 mm Hg OR diastolic BP ≥ 110 mm Hg) who receive treatment within 60 minutes of confirmation* will increase 10% each month of the initiative.

*Repeat BP within 15 minutes to confirm.
Measure 5: Unsure
Please explain.
Measure 6: Debriefs on all clinical situations involving new onset severe range hypertension*
- Yes
- No
- Unsure
The percent of clinical situations involving new onset severe range hypertension (systolic BP ≥ 160 mm Hg OR diastolic BP ≥ 110 mm Hg) that have documentation of a debrief* will increase 10% each month of the initiative.

*See Kilpatrick SJ et al. Standardized Severe Maternal Morbidity Review: Rationale and Process. Obstet Gynecol. 2014; 124(4):361-365 for an example of a debriefing tool.
Measure 6: Unsure
Please explain.
Measure 7: Severe maternal morbidity*
- Yes
- No
- Unsure
The percent of maternity patients with gestational hypertension or preeclampsia* of any severity, regardless of timing of onset, who receive a transfusion with ≥ 4 units blood and/or are admitted to the ICU will decrease by 10% during the initiative.

* Includes eclampsia and HELLP syndrome.
*Sites will select the target based on an assessment of their baseline.
Measure 7: Unsure
Please explain.
Can we list your site on the WisPQC Web site for this initiative?*
- Yes
- No
One of the strengths of a perinatal collaborative is the opportunity to develop relationships with new stakeholders. WisPQC wants to promote those relationships by listing the sites involved in initiatives on its Web site.

Hypertension Initiative Enrollment

WisPQC Hypertension Initiative Enrollment

Additional contacts

Measure Selection